Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12867998rdf:typepubmed:Citationlld:pubmed
pubmed-article:12867998lifeskim:mentionsumls-concept:C1257751lld:lifeskim
pubmed-article:12867998lifeskim:mentionsumls-concept:C0796355lld:lifeskim
pubmed-article:12867998lifeskim:mentionsumls-concept:C1330957lld:lifeskim
pubmed-article:12867998lifeskim:mentionsumls-concept:C0040648lld:lifeskim
pubmed-article:12867998lifeskim:mentionsumls-concept:C0378781lld:lifeskim
pubmed-article:12867998lifeskim:mentionsumls-concept:C1416745lld:lifeskim
pubmed-article:12867998lifeskim:mentionsumls-concept:C1425354lld:lifeskim
pubmed-article:12867998lifeskim:mentionsumls-concept:C0596311lld:lifeskim
pubmed-article:12867998lifeskim:mentionsumls-concept:C2587213lld:lifeskim
pubmed-article:12867998lifeskim:mentionsumls-concept:C0033268lld:lifeskim
pubmed-article:12867998pubmed:issue8lld:pubmed
pubmed-article:12867998pubmed:dateCreated2003-7-17lld:pubmed
pubmed-article:12867998pubmed:abstractTextSCL/Tal-1 is a helix-loop-helix (HLH) transcription factor required for blood cell development, whose abnormal expression is responsible for induction of T-cell acute lymphoblastic leukemia. We show here that SCL/Tal-1 is a key target of caspases in developing erythroblasts. SCL/Tal-1 degradation occurred rapidly after caspase activation and preceded the cleavage of the major erythroid transcription factor GATA-1. Expression of a caspase-resistant SCL/Tal-1 in erythroid progenitors was able to prevent amplification of caspase activation, GATA-1 degradation and impaired erythropoiesis induced by growth factor deprivation or death receptor triggering. The potent proerythropoietic activity of uncleavable SCL/Tal-1 was clearly evident in the absence of erythropoietin, a condition that did not allow survival of normal erythroid cells or expansion of erythroblasts expressing caspase-resistant GATA-1. In the absence of erythropoietin, cells expressing caspase-resistant SCL/Tal-1 maintain high levels of Bcl-X(L), which inhibits amplification of the caspase cascade and mediates protection from apoptosis. Thus, SCL/TAL-1 is a survival factor for erythroid cells, whereas caspase-mediated cleavage of SCL/Tal-1 results in amplification of caspase activation, GATA-1 degradation and impaired erythropoiesis.lld:pubmed
pubmed-article:12867998pubmed:languageenglld:pubmed
pubmed-article:12867998pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12867998pubmed:citationSubsetIMlld:pubmed
pubmed-article:12867998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12867998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12867998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12867998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12867998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12867998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12867998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12867998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12867998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12867998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12867998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12867998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12867998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12867998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12867998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12867998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12867998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12867998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12867998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12867998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12867998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12867998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12867998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12867998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12867998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12867998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12867998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12867998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12867998pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12867998pubmed:statusMEDLINElld:pubmed
pubmed-article:12867998pubmed:monthAuglld:pubmed
pubmed-article:12867998pubmed:issn1350-9047lld:pubmed
pubmed-article:12867998pubmed:authorpubmed-author:TestaUUlld:pubmed
pubmed-article:12867998pubmed:authorpubmed-author:PeschleCClld:pubmed
pubmed-article:12867998pubmed:authorpubmed-author:CondorelliGGlld:pubmed
pubmed-article:12867998pubmed:authorpubmed-author:MarianiGGlld:pubmed
pubmed-article:12867998pubmed:authorpubmed-author:FellsPPlld:pubmed
pubmed-article:12867998pubmed:authorpubmed-author:PelosiEElld:pubmed
pubmed-article:12867998pubmed:authorpubmed-author:De MariaRRlld:pubmed
pubmed-article:12867998pubmed:authorpubmed-author:AlnemriE SESlld:pubmed
pubmed-article:12867998pubmed:authorpubmed-author:ZeunerAAlld:pubmed
pubmed-article:12867998pubmed:authorpubmed-author:SrinivasulaS...lld:pubmed
pubmed-article:12867998pubmed:authorpubmed-author:EramoAAlld:pubmed
pubmed-article:12867998pubmed:issnTypePrintlld:pubmed
pubmed-article:12867998pubmed:volume10lld:pubmed
pubmed-article:12867998pubmed:ownerNLMlld:pubmed
pubmed-article:12867998pubmed:authorsCompleteYlld:pubmed
pubmed-article:12867998pubmed:pagination905-13lld:pubmed
pubmed-article:12867998pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12867998pubmed:meshHeadingpubmed-meshheading:12867998...lld:pubmed
pubmed-article:12867998pubmed:meshHeadingpubmed-meshheading:12867998...lld:pubmed
pubmed-article:12867998pubmed:meshHeadingpubmed-meshheading:12867998...lld:pubmed
pubmed-article:12867998pubmed:meshHeadingpubmed-meshheading:12867998...lld:pubmed
pubmed-article:12867998pubmed:meshHeadingpubmed-meshheading:12867998...lld:pubmed
pubmed-article:12867998pubmed:meshHeadingpubmed-meshheading:12867998...lld:pubmed
pubmed-article:12867998pubmed:meshHeadingpubmed-meshheading:12867998...lld:pubmed
pubmed-article:12867998pubmed:meshHeadingpubmed-meshheading:12867998...lld:pubmed
pubmed-article:12867998pubmed:meshHeadingpubmed-meshheading:12867998...lld:pubmed
pubmed-article:12867998pubmed:meshHeadingpubmed-meshheading:12867998...lld:pubmed
pubmed-article:12867998pubmed:meshHeadingpubmed-meshheading:12867998...lld:pubmed
pubmed-article:12867998pubmed:meshHeadingpubmed-meshheading:12867998...lld:pubmed
pubmed-article:12867998pubmed:meshHeadingpubmed-meshheading:12867998...lld:pubmed
pubmed-article:12867998pubmed:meshHeadingpubmed-meshheading:12867998...lld:pubmed
pubmed-article:12867998pubmed:meshHeadingpubmed-meshheading:12867998...lld:pubmed
pubmed-article:12867998pubmed:meshHeadingpubmed-meshheading:12867998...lld:pubmed
pubmed-article:12867998pubmed:meshHeadingpubmed-meshheading:12867998...lld:pubmed
pubmed-article:12867998pubmed:meshHeadingpubmed-meshheading:12867998...lld:pubmed
pubmed-article:12867998pubmed:meshHeadingpubmed-meshheading:12867998...lld:pubmed
pubmed-article:12867998pubmed:meshHeadingpubmed-meshheading:12867998...lld:pubmed
pubmed-article:12867998pubmed:meshHeadingpubmed-meshheading:12867998...lld:pubmed
pubmed-article:12867998pubmed:meshHeadingpubmed-meshheading:12867998...lld:pubmed
pubmed-article:12867998pubmed:meshHeadingpubmed-meshheading:12867998...lld:pubmed
pubmed-article:12867998pubmed:meshHeadingpubmed-meshheading:12867998...lld:pubmed
pubmed-article:12867998pubmed:meshHeadingpubmed-meshheading:12867998...lld:pubmed
pubmed-article:12867998pubmed:meshHeadingpubmed-meshheading:12867998...lld:pubmed
pubmed-article:12867998pubmed:meshHeadingpubmed-meshheading:12867998...lld:pubmed
pubmed-article:12867998pubmed:meshHeadingpubmed-meshheading:12867998...lld:pubmed
pubmed-article:12867998pubmed:meshHeadingpubmed-meshheading:12867998...lld:pubmed
pubmed-article:12867998pubmed:meshHeadingpubmed-meshheading:12867998...lld:pubmed
pubmed-article:12867998pubmed:meshHeadingpubmed-meshheading:12867998...lld:pubmed
pubmed-article:12867998pubmed:meshHeadingpubmed-meshheading:12867998...lld:pubmed
pubmed-article:12867998pubmed:meshHeadingpubmed-meshheading:12867998...lld:pubmed
pubmed-article:12867998pubmed:meshHeadingpubmed-meshheading:12867998...lld:pubmed
More...